The Preliminary Results of Intensity-Modulated Radiotherapy for Tonsillar Cancer |
Park, Geum-Ju
(Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine)
Lee, Sang-Wook (Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine) Choi, Eun-Kyung (Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine) Kim, Jong-Hoon (Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine) Song, Si-Yeol (Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine) Youn, Sang-Min (Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine) Park, Sung-Ho (Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine) Park, Dong-Wook (Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine) Ahn, Seung-Do (Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine) |
1 | Central Cancer Registry Center. Annual Report of the Central Cancer Registry in Korea, 2002. Seoul; Ministry of Health and Welfare, 2007 |
2 | Chao KS, Ozyigit G, Tran BN, Cengiz M, Dempsey JF, Low DA. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2003;55:312-321 DOI PUBMED ScienceOn |
3 | Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481 DOI ScienceOn |
4 | Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, Zelefsky MJ. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the memorial sloan-kettering experience. Int J Radiat Oncol Biol Phys 2006;64:57-62 DOI PUBMED ScienceOn |
5 | Chao KS. Dose prescription and target delineation for nodal volume. Philadelphia, PA; Lippincott Co, 2003 |
6 | Butler EB, Teh BS, Grant WH 3rd, et al. Smart (simultaneous modulated accelerated radiation therapy) boost:a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 1999;45:21-32 DOI PUBMED ScienceOn |
7 | Chao KS, Ozyigit G, Blanco AI, et al. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. Int J Radiat Oncol Biol Phys 2004;59:43-50 DOI PUBMED ScienceOn |
8 | Chao KS, Majhail N, Huang CJ, et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol 2001;61:275-280 DOI ScienceOn |
9 | American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th ed. New York; Springer, 2002 |
10 | Eisbruch A, Marsh LH, Dawson LA, et al. Recurrences near base of skull after IMRT for head-and-neck cancer:implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 2004;59:28-42 DOI PUBMED ScienceOn |
11 | Wu Q, Manning M, Schmidt-Ullrich R, et al. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments for head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys 2000;46:195-205 DOI ScienceOn |
12 | Sanguineti G, Gunn GB, Endres EJ, Chaljub G, Cheruvu P, Parker B. Patterns of locoregional failure after exclusive IMRT for oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2008;72:737-746 DOI PUBMED ScienceOn |
13 | Schoenfeld GO, Amdur RJ, Morris CG, et al. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2008;71:377-385 DOI PUBMED ScienceOn |
14 | Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48:7-16 DOI ScienceOn |
15 | de Arruda FF, Puri DR, Zhung J, et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 2006;64:363-373 DOI PUBMED ScienceOn |
16 | Park JH, Lee SW, Back GM, et al. Preliminary results of phase I/II study of simultaneous modulated accelerated (SMART) for nasopharyngeal carcinoma. J Korean Soc Ther Radiol Oncol 2006;24:1-10 |
17 | Devita VT, Lawrence TS, Steven A, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology. 8th ed. Philadelpia; Lippincott Williams & Wilkins, 2005:839-844 |
18 | Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-1346 DOI PUBMED ScienceOn |
19 | Chao KS, Deasy JO, Markman J, et al. A prospectiven study of salivary function sparing in patients with head-andneck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001;49:907-916 DOI ScienceOn |
20 | Bjordal K, Kaasa S, Mastekaasa A. Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys 1994;28:847-856 DOI PUBMED ScienceOn |
21 | Puri DR, Chou W, Lee N. Intensity-modulated radiation therapy in head and neck cancers: dosimetric advantages and update of clinical results. Am J Clin Oncol 2005;28:415-423 DOI ScienceOn |
22 | Chao KS, Low DA, Perez CA, Purdy JA. Intensity-modulated radiation therapy in head and neck cancers: the Mallinckrodt experience. Int J Cancer 2000;90:92-103 DOI ScienceOn |